Skip to main content

Trevena Inc(TRVN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Trevena Reports First Quarter 2022 Results and Provides Business Update

Globe Newswire - Wed May 11, 2022

OLINVYK refocused commercial strategy initiated mid-Q1

OLINVYK respiratory physiology study demonstrated statistically significant reduced impact on respiratory function compared to IV morphine, among elderly/overweight subjects

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe